Developer of therapies designed to provide treatment of retinal diseases. The company's KSI 301 helps to restore vision and stop progression of underlying disease, enabling healthcare providers to cure their patients.
Last Known Valuation2018-10-04
Company Financing Status
Kodiak Sciences News and Updates
iRhythm Technologies, Inc. (IRTC) Reaches $94.01 After 4.00% Up Move; WOUND MANAGEMENT TECHNOLOGIES (WNDM) Shorts Up By 2830%
The stock of iRhythm Technologies, Inc. (NASDAQ:IRTC) is a huge mover today! The stock increased 3.01% or $2.75 during the last trading session, reaching ...
The Moveefy | March 19, 2019
Reviewing Bio-Techne Corporation (TECH)'s and Kodiak Sciences Inc. (NASDAQ:KOD)'s results
This is a contrast between Bio-Techne Corporation (NASDAQ:TECH) and Kodiak Sciences Inc. (NASDAQ:KOD) based on their institutional ownership, earnings ...
The Yomi Blog | March 17, 2019
Reviewing Kodiak Sciences Inc. (KOD)'s and Sorrento Therapeutics Inc. (NASDAQ:SRNE)'s results
Both Kodiak Sciences Inc. (NASDAQ:KOD) and Sorrento Therapeutics Inc. (NASDAQ:SRNE) compete on a level playing field in the Biotechnology industry.
The Yomi Blog | March 12, 2019
Kodiak Sciences Primary Industry Sector / Group / Code